Addressing the Financial Burden of Cancer Treatment: From Copay to Can't Pay.

Patients with cancer spend a substantial amount of money on health care services and are at higher risk for financial hardship, including personal bankruptcy, than the general population. 1 Evidence that this so-called financial toxicity has a negative impact on clinical outcomes is emerging. High out-of-pocket spending on cancer treatment has been shown in recent studies to be associated with decreased treatment adherence and poorer quality of life. 2-4 The growing intersection between the financial and clinical aspects of cancer care represents an emerging challenge to the oncology community. In this article, we present 5 strategies to address the financial burden of cancer treatment.

[1]  D. Provenzale,et al.  Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. , 2015, Journal of oncology practice.

[2]  Spencer E. Harpe,et al.  Out-of-Pocket Costs and Oral Cancer Medication Discontinuation in the Elderly , 2014, Journal of managed care & specialty pharmacy.

[3]  Aaron N. Winn,et al.  Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  P. Newcomb,et al.  Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. , 2013, Health affairs.

[5]  S. Ramsey,et al.  Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. Ratain,et al.  Value-based insurance design: aligning incentives, benefits, and evidence in oncology. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.